Skip to main content
logo
Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
237.45
+7.90 (3.44%)
At close: May 19, 2026, 4:00 PM EDT
238.57
+1.12 (0.47%)
After-hours: May 19, 2026, 7:50 PM EDT

Jazz Pharmaceuticals Revenue by Segment

Period EndingMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Neuroscience
2.96B2.88B2.82B2.75B2.72B2.70B2.66B2.63B
Neuroscience Growth
8.81%6.68%6.01%4.40%3.25%-0.35%-3.68%-5.92%
Oncology
1.23B1.13B1.08B1.08B1.08B1.11B1.09B1.07B
Oncology Growth
13.79%1.56%-0.93%1.04%3.77%9.47%13.26%15.16%

Oncology Revenue Breakdown

Period EndingMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Rylaze Enrylaze
412.39M402.92M396.25M395.16M402.33M410.85M411.11M417.19M
Rylaze Enrylaze Growth
2.50%-1.93%-3.61%-5.28%-2.12%4.22%10.08%21.95%
Zepzelca
345.28M307.31M295.20M301.75M308.25M320.32M316.00M308.15M
Zepzelca Growth
12.01%-4.06%-6.58%-2.08%3.63%10.63%9.92%10.13%
Defitellio Defibtrotide
206.13M199.39M198.17M212.24M209.55M216.57M210.00M191.91M
Defitellio Defibtrotide Growth
-1.63%-7.93%-5.63%10.59%8.80%17.70%20.99%9.48%
Vyxeos
143.77M146.71M165.23M161.96M160.12M162.60M156.26M151.77M
Vyxeos Growth
-10.21%-9.77%5.74%6.71%12.11%10.24%19.42%15.78%
Modeyso
88.97M47.57M11.03M-----

Neroscience Revenue Breakdown

Period EndingMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Xywav
1.72B1.66B1.59B1.55B1.50B1.47B1.41B1.35B
Xywav Growth
14.49%12.48%13.00%14.58%14.67%15.73%15.77%18.46%
Epidiolex
1.09B1.06B1.05B996.07M991.44M972.42M938.00M900.15M
Epidiolex Growth
10.07%8.92%11.63%10.66%15.92%15.02%15.54%13.32%
Xyrem
139.99M146.03M157.54M179.99M206.83M233.82M291.25M358.24M
Xyrem Growth
-32.31%-37.54%-45.91%-49.76%-54.63%-58.96%-59.01%-57.42%
Sativex
10.87M16.28M19.95M19.78M21.55M18.88M18.84M18.88M
Sativex Growth
-49.56%-13.77%5.87%4.76%40.80%-4.02%-2.13%5.81%
Source: Business metrics provided by TipRanks and sourced from official company press releases and documents.